Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 16, 2007
Issued Date -
N/A
app pub date -
Nov 25, 2003
filing date -
Sep 6, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully